한글목차

약물 유전학 검사 시장 규모는 최근 급성장하고 있습니다. 2025년 143억 3,000만 달러에서 2026년에는 165억 8,000만 달러에 이르고, CAGR 15.7%의 성장이 전망되고 있습니다. 지난 수년간의 성장 요인으로는 유전체 염기서열 분석 기술의 발전, 약물 부작용에 대한 우려, 만성질환 부담 증가, 유전자 검사 비용 감소, 임상현장에서의 인지도 향상 등을 꼽을 수 있습니다.

약물 유전학 검사 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 295억 5,000만 달러에 이르고, CAGR은 15.5%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 정밀의료의 발전, 소비자 직접 검사 확대, 전자 건강 기록과의 통합, 규제 지원 강화, 유전체 연구에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인 맞춤형 의료 도입 확대, 약물 선택 시 유전자 검사 활용 증가, 종양학 및 심장병학 분야에서의 적용 확대, 정밀 진단 수요 증가, 임상 현장에서의 약리유전체학 통합 등을 꼽을 수 있습니다.

개인 맞춤형 의료에 대한 수요 증가는 향후 약리유전학 검사 시장의 확대를 촉진할 것으로 예측됩니다. 맞춤형 의료(정밀의료라고도 함)는 개인의 고유한 유전적, 생물학적, 생활습관적 요인에 따라 치료법이나 판단을 맞춤화하는 의료 전략입니다. 치료 효과 향상, 조기 발견, 의료 비용 효율성 향상으로 이어질 수 있기 때문에 이 수요는 확대되고 있습니다. 약리유전학적 검사는 환자의 유전자 구성을 분석하여 약물 반응을 예측함으로써 개인 맞춤형 의료를 지원하고, 보다 적절한 치료 선택을 가능하게 하며, 부작용을 최소화합니다. 예를 들어, 2024년 2월 미국 비영리단체인 맞춤형 의료연합(PMC)이 발표한 바에 따르면, 2023년 FDA가 승인한 희귀질환에 대한 신규 개인맞춤형 치료제는 16건으로 2022년 6건보다 증가했다고 합니다. 이처럼 개인 맞춤형 의료에 대한 수요 증가가 약물유전학 검사 시장의 성장을 견인하고 있습니다.

약리유전학 검사 시장의 주요 기업들은 약물의 안전성 향상, 치료 정확도 향상, 맞춤형 치료 선택 촉진 등을 위해 처방전 기반 약리유전학 검사를 포함한 고급 약리유전학 검사 서비스 개발에 우선순위를 두고 있습니다. 처방전 기반 약리유전학 검사는 자격을 갖춘 의료진이 처방하는 유전자 검사로, 개인의 유전적 프로파일이 특정 약물에 대한 반응에 미치는 영향을 평가합니다. 이를 통해 의사는 약물 선택과 용량을 최적화하고 부작용 위험을 줄일 수 있습니다. 예를 들어, 2023년 5월, 미국 캘리포니아대학교 샌프란시스코 캠퍼스(UCSF)는 치료의 정확성을 높이기 위해 약리유전체학 검사 서비스를 도입했습니다. 이 서비스를 통해 임상의는 개별 환자 프로파일에 맞게 약물 치료를 맞춤화하여 약물의 효과를 높이고 심각한 부작용의 가능성을 줄일 수 있는 유전자 데이터를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pharmacogenetic testing involves genetic analysis that reveals how a person's genes affect their response to particular drugs, enabling customized medication strategies for improved effectiveness and fewer adverse effects. This individualized method improves patient outcomes by aligning treatments with genetic characteristics. It finds broad application in areas like oncology, psychiatry, and cardiology.

The primary types of pharmacogenetic testing include whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing offers a thorough approach to examining an organism's full genome. It sequences all DNA in one test, delivering a detailed view of a person's genetic profile. Drug types encompass prescription medications, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter drugs across various therapeutic fields like cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and more. These are available via hospital pharmacies, retail pharmacies, mail-order pharmacies, and direct-to-consumer channels, serving end users such as healthcare providers, pharmaceutical and biotechnology firms, research centers, academic institutions, and others.

Tariffs have impacted the pharmacogenetic testing market by raising the cost of imported sequencing instruments, reagents, and assay components used in genetic analysis. These effects are most pronounced in Asia Pacific and emerging markets that rely heavily on imported diagnostic technologies. Rising tariff related costs have increased testing expenses and influenced laboratory investment decisions. This has affected the pace of pharmacogenetic test adoption in clinical and research settings. However, tariffs are also supporting the development of domestic diagnostic manufacturing, local assay production, and stronger regional testing ecosystems over time.

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides pharmacogenetic testing market statistics, including pharmacogenetic testing industry global market size, regional shares, competitors with a pharmacogenetic testing market share, detailed pharmacogenetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. This pharmacogenetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $14.33 billion in 2025 to $16.58 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to advances in genomic sequencing technologies, adverse drug reaction concerns, rising chronic disease burden, declining genetic testing costs, increased clinical awareness.

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $29.55 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to growth of precision healthcare, expansion of direct-to-consumer testing, integration with electronic health records, increasing regulatory support, rising investment in genomics research. Major trends in the forecast period include rising adoption of personalized medicine, increasing use of genetic testing in drug selection, expansion of oncology and cardiology applications, growing demand for precision diagnostics, integration of pharmacogenomics in clinical practice.

The rising demand for personalized medicine is anticipated to fuel the expansion of the pharmacogenetic testing market in the future. Personalized medicine, also known as precision medicine, involves a medical strategy that customizes treatments and decisions based on a person's distinct genetic, biological, and lifestyle factors. This demand is growing because it enhances treatment effectiveness, enables earlier detection, and boosts cost-efficiency in healthcare. Pharmacogenetic testing aids personalized medicine by examining a patient's genetic makeup to forecast drug responses, allowing for better treatment choices and minimizing adverse effects. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from 6 in 2022. Thus, the growing need for personalized medicine is propelling the pharmacogenetic testing market forward.

Major companies in the pharmacogenetics testing market are prioritizing the development of sophisticated pharmacogenomics testing services, including prescription-based pharmacogenetic testing, to boost medication safety, enhance treatment accuracy, and facilitate personalized therapeutic choices. Prescription-based pharmacogenetic testing involves genetic testing prescribed by qualified healthcare providers to assess how a person's genetic profile affects their response to particular drugs, enabling doctors to refine drug selection and dosage to lower the risk of adverse reactions. For example, in May 2023, UCSF, a US-based healthcare provider, introduced its pharmacogenomics testing service to increase the precision of medical treatments, offering clinicians genetic data that allows them to customize drug therapies to individual patient profiles, boost drug effectiveness, and reduce the chance of serious side effects.

In May 2023, HealthOme-a US-based company focused on advanced genetic testing and personalized medicine-acquired Kailos Genetics for an undisclosed sum. The deal bolsters HealthOme's personalized medicine offerings by incorporating Kailos Genetics' cutting-edge genomic technologies and pharmacogenetic expertise. It also amplifies HealthOme's capacity to provide full-spectrum precision-testing services via deeper knowledge in genomic analysis and tailored treatment recommendations. Kailos Genetics, a US-based firm, delivers pharmacogenetic testing via its Inspexion platform.

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacogenetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmacogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmacogenetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Whole Genome Sequencing; Whole Exome Sequencing; Array-Based Tests; Single Gene Tests
• 2) By Drug Type: Prescription Drugs; Nutraceuticals; Recreational Drugs; Herbal Supplements; Vitamins; Over-The-Counter Medications
• 3) By Therapeutic Area: Cardiology; Gastroenterology; Anesthesiology; Genomics; Endocrinology; Immunology And Hypersensitivity; Dermatology; Gynecology; Oncology; Other Therapeutic Areas
• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Mail-Order Pharmacies; Direct-to-Customer Services
• 5) By End User: Healthcare Providers; Pharmaceutical And Biotechnology Companies; Centers And Academic Institutes; Other End Users
• Subsegments:
• 1) By Whole Genome Sequencing: Illumina Sequencing; Ion Torrent Sequencing; Pacific Biosciences Sequencing; Oxford Nanopore Sequencing
• 2) By Whole Exome Sequencing: Capture-Based Exome Sequencing; Targeted Enrichment Exome Sequencing; Hybridization-Based Exome Sequencing
• 3) By Array-Based Tests: SNP Array Testing; Expression Array Testing; Copy Number Variation Array Testing
• 4) By Single Gene Tests: Targeted Gene Panels; Mutation Detection Tests; Sequencing Of Specific Genes
• Companies Mentioned: CVS Health Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Eurofins Scientific Inc.; Bio-Rad Laboratories; Precision Medicine Advsiors; Azenta Life Sciences; Fulgent Genetics; Pacific Biosciences of California Inc.; Castle Biosciences; 23andMe Holding Co.; Helix Inc.; Genomind Inc.; MD Labs; Sonic Genetics; AutoGenomics Inc.; LabClinics SA; Gene By Gene Ltd.; Xcode Life Sciences; YouScript; RxGenomix LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmacogenetic Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmacogenetic Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmacogenetic Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmacogenetic Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Personalized Medicine
  • 4.2.2 Increasing Use Of Genetic Testing In Drug Selection
  • 4.2.3 Expansion Of Oncology And Cardiology Applications
  • 4.2.4 Growing Demand For Precision Diagnostics
  • 4.2.5 Integration Of Pharmacogenomics In Clinical Practice

5. Pharmacogenetic Testing Market Analysis Of End Use Industries

• 5.1 Healthcare Providers
• 5.2 Hospitals
• 5.3 Diagnostic Laboratories
• 5.4 Pharmaceutical Companies
• 5.5 Academic Research Centers

6. Pharmacogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmacogenetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmacogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmacogenetic Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmacogenetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmacogenetic Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmacogenetic Testing Market Segmentation

• 9.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests
• 9.2. Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications
• 9.3. Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas
• 9.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services
• 9.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users
• 9.6. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing
• 9.7. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing
• 9.8. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing
• 9.9. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

10. Pharmacogenetic Testing Market Regional And Country Analysis

• 10.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmacogenetic Testing Market

• 11.1. Asia-Pacific Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmacogenetic Testing Market

• 12.1. China Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmacogenetic Testing Market

• 13.1. India Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmacogenetic Testing Market

• 14.1. Japan Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmacogenetic Testing Market

• 15.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmacogenetic Testing Market

• 16.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmacogenetic Testing Market

• 17.1. South Korea Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmacogenetic Testing Market

• 18.1. Taiwan Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmacogenetic Testing Market

• 19.1. South East Asia Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmacogenetic Testing Market

• 20.1. Western Europe Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmacogenetic Testing Market

• 21.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmacogenetic Testing Market

• 22.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmacogenetic Testing Market

• 23.1. France Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmacogenetic Testing Market

• 24.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmacogenetic Testing Market

• 25.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmacogenetic Testing Market

• 26.1. Eastern Europe Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmacogenetic Testing Market

• 27.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmacogenetic Testing Market

• 28.1. North America Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmacogenetic Testing Market

• 29.1. USA Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmacogenetic Testing Market

• 30.1. Canada Pharmacogenetic Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmacogenetic Testing Market

• 31.1. South America Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmacogenetic Testing Market

• 32.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmacogenetic Testing Market

• 33.1. Middle East Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmacogenetic Testing Market

• 34.1. Africa Pharmacogenetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmacogenetic Testing Market Regulatory and Investment Landscape

36. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

• 36.1. Pharmacogenetic Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmacogenetic Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmacogenetic Testing Market Company Profiles
  • 36.3.1. CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Eurofins Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bio-Rad Laboratories Overview, Products and Services, Strategy and Financial Analysis

37. Pharmacogenetic Testing Market Other Major And Innovative Companies

• Precision Medicine Advisors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript

38. Global Pharmacogenetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

40. Pharmacogenetic Testing Market High Potential Countries, Segments and Strategies

• 40.1 Pharmacogenetic Testing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmacogenetic Testing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmacogenetic Testing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer